MAPK3 and lung carcinoma: To evaluate the expression of HO-1 in primary tumors, we employed human lung carcinoma specimens from 30 patients and performed immunohistochemical analysis of HO-1, Notch1 and P-Erk1/2 in these samples (Figure 6).